Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
A cofounder is suing after being fired for not returning to the office, claiming the mandate applied to employees but...
Oracle delivered a standout quarter, signaling AI investments and data-center expansion can pay off. The company rais...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
Quantum computing could redefine Bitcoin security. Glassnode highlights exchange-held coins as a critical vulnerabili...
Better Home & Finance signs a tokenized funding deal with Framework Ventures to access up to $500 million in credit v...
RZC Investments, the Walton family–funded private equity arm, has paused new investments while it reevaluates its fun...
A niche shipping ETF has delivered extraordinary gains in 2026, turning a $100,000 investment into several million as...
Four high-profile tech names have shed 23% to 37% in 2026 as the Nasdaq edges higher. Analysts see substantial upside...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
TON climbs from about $1.30 to $2.50 in three days as Telegram signals a major governance shift, slashing fees and ta...
Retirees should stay alert as the social security cola update unfolds. This guide explains how COLA works, which numb...